Centre provides over 57 crore vaccine doses to states and UTs
Over 13 crore doses are in the pipeline
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Zydus Cadila gets US FDA approval for Tofacitinib extended-release 22 mg tablet
Zydus was the first ANDA filer on Tofacitinib extended-release tablets 22 mg and
currently holds 180-day exclusivity on this…
Xeljanz receives marketing authorisation in EU to treat active polyarticular juvenile idiopathic…
This once-daily treatment is an alternative to the currently-approved Xeljanz 5 mg twice-daily treatment of PsA
J&J seeks Indian regulator’s nod for COVID vaccine trials on adolescents
Earlier this month, the government had given Emergency Use approval to J&J’s single-dose COVID vaccine in India
Zydus Cadila’s COVID vaccine ZyCoV-D gets approval for Emergency Use Authorisation
With EUA, ZyCoV-D has also become the first vaccine to be administered to those in the age group of 12-18 years in the country
AstraZeneca and Sputnik V vaccines’ combination show high immunogenicity, says RDIF
RDIF, the Gamaleya Center, AstraZeneca and R-Pharm signed a Memorandum of Intent aimed at cooperation in conducting a joint…
NRx Pharmaceuticals announces positive safety report for Zyesami in NIH-sponsored ACTIV-3 study in…
ACTIV-3 Critical Care is evaluating Zyesami and Remdesivir in critical COVID-19 patients as monotherapy, and in combination…
Zydus partners with CHEMI to launch enoxaparin sodium injection
Under the agreement, CHEMI will manufacture and supply the enoxaparin sodium injection, which Zydus will commercialise in the US
US FDA approves Jardiance to treat adults living with heart failure with reduced ejection fraction
Heart failure accounts for more than one million hospitalisations a year in the US
Sorrento’s vaccine shows promise against coronavirus, variants in animal studies
The sera of vaccinated mice showed neutralisation of infection caused by the original coronavirus and major variants of concern…